1.19

3.25% -0.04

Pre-market: 1.21 0.02 +1.68%

Lexaria Bioscience Corp (LEXX)

Overview News Price History Financials Discussions Forecast Stock Split

Lexaria Bioscience Corp stock is traded at $1.19, with a volume of 127.51K. It is down -3.25% in the last 24 hours and down -28.74% over the past month. Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Previous Close:

$1.23

Open:

$1.23

24h Volume:

127.51K

Relative Volume:

1.27

Market Cap:

$23.70M

Revenue:

$411.00K

Net Income/Loss:

$-4.85M

P/E Ratio:

-2.7045

EPS:

-0.44

Net Cash Flow:

$-4.88M

1W Performance:

-11.85%

1M Performance:

-28.74%

6M Performance:

-48.71%

1Y Performance:

-60.33%

1-Day Range:

$1.185

$1.23

1-Week Range:

$1.14

$1.28

52-Week Range:

$1.14

$4.44

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Name

Lexaria Bioscience Corp

Sector

Healthcare (1151)

Industry

Biotechnology (677)

Phone

250-765-6424

Address

100 - 740 MCCURDY ROAD, KELOWNA

Employee

Twitter

Next Earnings Date

2025-04-28

Latest SEC Filings

LEXX's Discussions on Twitter

Compare LEXX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LEXX Lexaria Bioscience Corp	1.19	23.70M	411.00K	-4.85M	-4.88M	-0.44
VRTX Vertex Pharmaceuticals Inc	501.15	126.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	605.61	65.06B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	649.67	37.54B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	259.39	32.56B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	255.77	26.40B	3.81B	-644.79M	-669.77M	-6.24

Lexaria Bioscience Corp Stock (LEXX) Latest News

May 03, 2025

Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 03, 2025

May 01, 2025

Lexaria Bioscience announces $2M registered direct offering; shares slip 19% - MSN

May 01, 2025

Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 By Investing.com - Investing.com India

Apr 30, 2025

Lexaria Bioscience stock hits 52-week low at $1.14 - Investing.com Australia

Apr 30, 2025

Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offeri - GuruFocus

Apr 28, 2025

Lexaria Announces Closing of $2 Million Registered Direct Offering of Common Stock - Yahoo Finance

Apr 28, 2025

Lexaria Bioscience Secures $2 Million in Direct Stock Offering - TipRanks

Apr 28, 2025

Lexaria Secures $2M Strategic Investment in Clean Direct Offering Amid Market Turbulence - Stock Titan

Apr 28, 2025

Market Watch Highlights: Lexaria Bioscience Corp (LEXX) Ends on an Downturn Note at 1.35 - DWinneX

Apr 28, 2025